Journal of Nanomedicine & Biotherapeutic Discovery

Journal of Nanomedicine & Biotherapeutic Discovery
Open Access

ISSN: 2155-983X

Kerriann Greenhalgh

Kerriann Greenhalgh
MiMedx Group Inc.


Dr. Kerriann Greenhalgh received her PhD in Organic Chemistry at the University of South Florida during the period of August 2004 to December 2007. Currently, she is working as the Senior Project Engineer at MiMedx Group in Tampa, FL a biomedicalbased orthopedics and wound care company that is developing combinatorial products that include collagen and polymerbased nanoparticles. She is serving as a reviewer of several reputed journals like Food and Chemical Toxicology, Nanomedicine: Nanotechnology, Biology, and Medicine, Journal of Applied Polymer Science, Recent Patents on Inflammation Allergy Drug Discovery, and Journal of Controlled Release.


Research Interest

Dr. Greenhalgh´s research interest include development of polyacrylate-based nanoparticles for application in wound care, infectious disease, general surgery, and cardiology. She has developed multiple collagen-nanoparticle formulations and has prototyped over 20 different artificial vessels using her patented technology. Interests also include treatment of infectious diseases and cancer with drug conjugated nanoparticles and has had at least 3 funded projects in this area.